Cargando…

The anti-tumor effects of cetuximab in combination with VTX-2337 are T cell dependent

The Toll-like receptor 8 (TLR8) agonist VTX-2337 (motolimod) is an anti-cancer immunotherapeutic agent that is believed to augment natural killer (NK) and dendritic cell (DC) activity. The goal of this work is to examine the role of TLR8 expression/activity in head and neck squamous cell carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yinwen, Borcherding, Nicholas, Ogunsakin, Ayomide, Lemke-Miltner, Caitlin D., Gibson-Corley, Katherine N., Rajan, Anand, Choi, Allen B., Wongpattaraworakul, Wattawan, Chan, Carlos H. F., Salem, Aliasger K., Weiner, George J., Simons, Andrean L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810827/ https://www.ncbi.nlm.nih.gov/pubmed/33452311 http://dx.doi.org/10.1038/s41598-020-80957-z

Ejemplares similares

In situ immunization of a TLR9 agonist virus-like particle enhances anti-PD1 therapy
por: Cheng, Yinwen, et al.
Publicado: (2020)

Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma
por: Wongpattaraworakul, Wattawan, et al.
Publicado: (2022)

TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
por: Lu, Hailing, et al.
Publicado: (2013)

Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
por: Dietsch, Greg, et al.
Publicado: (2014)

Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)
por: Ferris, Robert L, et al.
Publicado: (2014)

Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
por: Dietsch, Gregory N., et al.
Publicado: (2016)

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2019)

Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to Vidutolimod
por: Sabree, Shakoora A., et al.
Publicado: (2021)

The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes
por: Dowling, David J., et al.
Publicado: (2013)

Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas
por: Rajan, Anand, et al.
Publicado: (2019)

Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8(+) T cells in the mouse
por: Lemke, Caitlin D., et al.
Publicado: (2011)

The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
por: Geary, Sean M., et al.
Publicado: (2013)

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2019)

Whole genome sequence comparison of vtx2-converting phages from Enteroaggregative Haemorrhagic Escherichia coli strains
por: Grande, Laura, et al.
Publicado: (2014)

PReS-FINAL-2337: The eurofever registry: 3 years of enrollment
por: Federici, S, et al.
Publicado: (2013)

Characterization of CPH:SA microparticle‐based delivery of interleukin‐1 alpha for cancer immunotherapy
por: Hasibuzzaman, M. M., et al.
Publicado: (2022)

VTX‐1463, a novel TLR‐8 agonist, attenuates nasal congestion after ragweed challenge in sensitized beagle dogs
por: Royer, Christopher M., et al.
Publicado: (2015)

Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma
por: Stanam, Aditya, et al.
Publicado: (2016)

VTX‐1 Liquid Biopsy System for Fully‐Automated and Label‐Free Isolation of Circulating Tumor Cells with Automated Enumeration by BioView Platform
por: Sollier‐Christen, Elodie, et al.
Publicado: (2018)

2337: Doxorubicin exposure in vitro stimulates ROS production and directly suppresses cardiac fibroblast proliferation
por: Mancilla, Trevi A., et al.
Publicado: (2018)

2337. Clinical Characteristics of Children Infected With Macrolide-Resistant Mycoplasma Pneumonia in Central Ohio—Preliminary Data
por: Piazzon, Mariana Lanata, et al.
Publicado: (2018)

2337. Health Outcomes in Congenital Cytomegalovirus, a Systematized and Unbiased Approach in the Electronic Medical Record Era
por: Rochat, Ryan H, et al.
Publicado: (2019)

The Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiation
por: Simons, Andrean L., et al.
Publicado: (2013)

Loss of vtx Genes after the First Subcultivation Step of Verocytotoxigenic Escherichia coli O157 and Non-O157 during Isolation from Naturally Contaminated Fecal Samples
por: Joris, Maria-Adelheid, et al.
Publicado: (2011)

PB2337: SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA
por: Zhang, Zhipeng, et al.
Publicado: (2023)

miR-2337 induces TGF-β1 production in granulosa cells by acting as an endogenous small activating RNA
por: Wang, Lingfang, et al.
Publicado: (2021)

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2022)

Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
por: Wang, Zhaoming, et al.
Publicado: (2021)

Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy. Diabetes 2009;58:934–945. DOI: 10.2337/db08-1287
por: Francis, George, et al.
Publicado: (2014)

Statement of Retraction. Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets. Diabetes 2008;57:645–653. DOI: 10.2337/db07-0847; and erratum. Diabetes 2014:63:3974. DOI: 10.2337/db14-er11
por: Shu, Luan, et al.
Publicado: (2017)

Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
por: Borcherding, Nicholas, et al.
Publicado: (2021)

Prostate cancer vaccines: Update on clinical development
por: Geary, Sean M., et al.
Publicado: (2013)

Anaphylactoid hypersensitivity reaction from intra-arterial cetuximab: Clinical considerations and management
por: Bardash, Yonatan, et al.
Publicado: (2019)

PB2337: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH VENO-OCCLUSIVE DISEASE (VOD): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
por: Aggarwal, S., et al.
Publicado: (2022)

Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
por: Chen, Alessandra, et al.
Publicado: (2018)

Erratum: Delayed Response to U-500 Regular Insulin. Clinical Diabetes 2018;36: 77–79 (DOI: 10.2337/cd16-0058)
por: Davidson, Mayer B.
Publicado: (2018)

Erratum. Diabetic Gastroparesis: A Review. Diabetes Spectrum 2020;33:290–297 (https://doi.org/10.2337/ds19-0062)
por: Young, Clipper F., et al.
Publicado: (2020)

Erratum. Therapeutic Inertia Is a Problem for All of Us. Clinical Diabetes 2019;37:105–106 (DOI: 10.2337/cd19-0009)
por: Brunton, Stephen A.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4spda7dmkdpm221hejpf84448n